β-arrestin protects neurons by mediating endogenous opioid arrest of inflammatory microglia

X. Feng, Cheng-Ying Wu, F. H. Burton, Horace H Loh, Li-Na Wei

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Microglial activation worsens neuronal loss and contributes to progressive neurological diseases like Parkinson's disease (PD). This inflammatory progression is countered by dynorphin (Dyn), the endogenous ligand of the kappa-opioid receptor (KOR). We show that microglial β-arrestin mediates the ability of Dyn/KOR to limit endotoxin-elicited production of pro-inflammatory effectors and cytokines, subsequently protecting neurons from inflammation-induced neurotoxicity. Agonist-activated KOR enhances the interaction of β-arrestin2 with transforming growth factor-beta-activated kinase 1 (TAK1)-binding protein 1 (TAB1), disrupting TAK1-TAB1 mediated pro-inflammatory gene expression. We reveal a new physiological role for β-arrestin in neuroprotection via receptor internalization-triggered blockade of signal effectors of microglial inflammatory neurotoxicity. This result offers novel drug targets in the convergent KOR/β-arrestin2 and inflammatory pathways for treating microglial inflammatory neuropathologies like PD.

Original languageEnglish (US)
Pages (from-to)397-406
Number of pages10
JournalCell Death and Differentiation
Volume21
Issue number3
DOIs
StatePublished - Mar 1 2014

    Fingerprint

Keywords

  • dynorphin
  • kappa-opioid receptor
  • microglial inflammation
  • neurotoxicity
  • β-arrestin

Cite this